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SingaporeABSTRACT The spatial arrangement of the epidermal growth factor receptor (EGFR) on the cellular plasma membrane is one
of the prime factors that control its downstream signaling pathways and related functions. However, the molecular organization,
which spans the scale from nanometers to micrometer-size clusters, has not been resolved in detail, mainly due to a lack of
techniques with the required spatiotemporal resolution. Therefore, we used imaging total internal reflection-fluorescence corre-
lation spectroscopy to investigate EGFR dynamics on live CHO-K1 plasma membranes in resting and ligand-bound states. In
combination with the fluorescence correlation spectroscopy diffusion law, this provides information on the subresolution orga-
nization of EGFR on cell membranes. We found that overall EGFR organization is sensitive to both cholesterol and the actin
cytoskeleton. EGFR in the resting state is partly trapped in cholesterol-containing domains, whereas another fraction exhibits
cholesterol independent trapping on the membrane. Disruption of the cytoskeleton leads to a broader range of EGFR diffusion
coefficients and a reduction of hop diffusion. In the ligand-bound state we found a dose-dependent behavior. At 10 ng/mL EGF
the EGFR is endocytosed and recycled to the membrane, whereas diffusion and organization do not change significantly. At
100 ng/mL EGF the EGFR forms clusters, which are subsequently internalized, whereas outside the clusters diffusivity in-
creases and the organization of the receptor remains unchanged. After disruption of cholesterol-containing domains or actin
cytoskeleton, EGF induces microscopic EGFR clusters on the membrane and endocytosis is inhibited.INTRODUCTIONEpidermal growth factor receptor (EGFR) is a prototypical
receptor tyrosine kinase that belongs to the ErbB family. It
is a key regulator of a variety of physiological processes
ranging from cell proliferation to apoptosis (1). EGFR
activation leads to signal transduction and initiation of
various downstream signaling cascades (2). It is believed
that EGFR is inhomogeneously distributed on the mem-
brane and its oligomeric state, on which its functions
strongly depend, is majorly dictated by this organization
and concomitant dynamics (3,4). It was recently shown,
by combination of experiments and molecular dynamics
simulations, that the interaction of EGFR with the sur-
rounding lipid bilayer on plasma membranes plays a
fundamental role in the formation of active dimers after
ligand binding (5,6). However, the membrane organization
of EGFR and its relationship to the ligand-induced clus-
tering, phosphorylation, and endocytosis are controversial
(7–9). This is mainly due to the complex organization of
plasma membranes, exhibiting patterns on a wide range
of spatial and temporal scales (10). Nevertheless, EGFR
oligomerization pre- and postligand stimulation is linked
with its lateral dynamics and organization on the plasmaSubmitted July 6, 2015, and accepted for publication September 8, 2015.
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0006-3495/15/11/1925/12membrane, which in turn has a strong effect on EGFR
signaling (11–13).
According to the classical description of the plasma
membrane organization, a variety of ordered domains with
distinct physicochemical properties are embedded within
the phospholipid bilayer matrix. These domains, depending
on their composition, are generally categorized as choles-
terol- and sphingolipid-enriched lipid rafts, cholesterol and
glycolipid-containing caveolae, and cholesterol-deficient
domains such as ganglioside domains. Membrane proteins
are often found to have a preferred localization in these
domains. Glycosylphosphatidylinositol anchored proteins
(GPI-APs) and caveolin-1 are found in lipid rafts and caveo-
lae, respectively (14,15). Membrane domains, in the resting
cells, are believed to be randomly distributed over the entire
membrane and act as transient trapping sites of localized
biomolecules (16). In parallel, the actin cytoskeleton mesh-
work creates a spatial pattern underneath the membrane that
can influence the membrane organization. Transmembrane
proteins are often immobilized at the mesh boundary (17).
The mesh boundary along with the immobilized proteins
poses a barrier against free diffusion across the membrane
plane. Transient trapping in membrane domains and diffu-
sion barriers formed by the cytoskeleton meshwork result
in non-Brownian membrane diffusion (18). This unique ar-
chitecture of membranes plays a pivotal role in biological
functions, including the oligomerization state of membranehttp://dx.doi.org/10.1016/j.bpj.2015.09.007
1926 Bag et al.proteins, signal transduction, endocytosis, and cell-cell
communication (19).
Here, we quantitate the lateral diffusion and organization
of EGFR in resting and ligand-bound states on live CHO-K1
plasma membranes at physiological conditions by imaging
total internal reflection-fluorescence correlation spectros-
copy (ITIR-FCS) where the membrane-bound fluorophores
are excited with TIR illumination and the fluorescence
signal is collected by a fast and sensitive camera (20).
ITIR-FCS breaks the single spot limitation of conventional
FCS by performing FCS experiments on thousands of
contiguous spots in parallel and provides diffusion coeffi-
cient (D) maps of a sample. However, ITIR-FCS is a
diffraction-limited technique, whereas the receptor spatial
heterogeneity is on the nanometer scale. To address this lim-
itation, we adopted the FCS diffusion law (21) for ITIR-
FCS. The dependence of the diffusion time of a probe
molecule (tD ¼Aeff/D) on the size of the observation area
(Aeff) gives rise to the FCS diffusion law plot (Eq. S2 in
the Supporting Material). This plot, when extrapolated to
zero, yields the FCS diffusion law intercept (t0), which pro-
vides information on the spatial organization of the probe
below the diffraction limit. The value of t0 is zero for free
diffusion, positive for transient confinement in domains,
and negative for hop diffusion due to a meshwork (21,22).
Note that both transient molecular trapping in lipid domains
and assembly of proteins to form transient clusters followed
by disassembly give rise to positive intercept in the FCS
diffusion law plot. In the first case, the trapping time of
the probe molecule is smaller than the lifetime of the do-
mains. In contrast, the trapping time and domain lifetime
are the same in the second case. The FCS diffusion law
can be easily implemented in ITIR-FCS, as observation
areas of different size can be created by pixel binning of
the recorded image stack. Thus, ITIR-FCS in combination
with the FCS diffusion law extracts subresolution informa-
tion of living systems from diffraction-limited measure-
ments and thus is an ideal choice to observe nanoscale
spatiotemporal organization of membrane receptors.
We first performed proof-of-principle experiments on
DiI-C18, green fluorescent protein (GFP)-GPI-AP, and a
GFP fused to a plasma membrane targeting sequence
(PMT-GFP) on CHO-K1 cells to confirm that they undergo
free diffusion, cholesterol-dependent domain confined diffu-
sion, and actin-dependent hop diffusion, respectively. The
dynamics and organization of EGFR-EGFP is found to be
more complex. In the resting state, the receptor is spatially
confined on the cell membrane in a cholesterol and cortical
actin dependent manner. Moreover, a significant amount of
cholesterol-independent trapping of EGFR-EGFP diffusion
was also observed. This either could originate from dynamic
partitioning of EGFR in the cholesterol-independent do-
mains or by the formation of receptor clusters. The organiza-
tional features change significantlywhenEGFR is stimulated
with its cognate ligand, epidermal growth factor (EGF). TheBiophysical Journal 109(9) 1925–1936diffusivity, clustering, and internalization of EGFR are
dependent on ligand dose.We further observed that the inter-
nalization of the ligand-bound EGFR is compromised in the
absence of cholesterol-dependent domains or after actin
cytoskeleton disruption, both of which allow EGFR clusters
to stay on the membrane for a longer time.MATERIALS AND METHODS
Protocols for the preparation of lipid bilayers, cell culture, transfection, chem-
ical labeling, and drug treatment are provided in detail in the Supporting
Material. The imaging setup, data acquisition, and analysis procedures are re-
ported elsewhere (23–26) and also given briefly in the Supporting Material.RESULTS AND DISCUSSION
ITIR-FCS was employed to quantify the distribution of the
lateral diffusion coefficient (D) of EGFR-EGFP, whereas
FCS diffusion law analysis was performed on the same set
of data to understand its spatial heterogeneity in terms of
transient trapping inside membrane domains or clustering
and compartmentalization due to the actin network. The
FCS diffusion law intercept (t0) quantitatively describes ob-
structed diffusion in these cases. The t0 is positive for tran-
sient trapping or clustering and negative for meshwork
compartmentalization. The magnitude of t0 for domain
confinement increases with confinement size, confinement
time, and partitioning into the domains. The value of t0
for hop diffusion across a meshwork depends on the size
and density of the mesh and the hopping frequency of the
probe molecules. The change of membrane diffusion and
confinement of EGFR-EGFP is compared to those of a
well-established lipid raft marker, GFP-GPI-AP, and freely
diffusing probe, DiI-C18, after cholesterol depletion or actin
depolymerization. By connecting these observations, we
construct the spatial arrangement of EGFR on the plasma
membrane and also address individual contributions from
each of the organizational elements. We further explore
how this organization in the resting state is modified after
stimulation with high and low doses of EGF. Imaging of
ligand-induced EGFR endocytosis and microscopic clus-
tering corroborates the cell surface organization, deduced
from the FCS diffusion law analysis.
EGFP was fused at the C-terminus of EGFR. The plasmid
map has been previously published (27). Methyl beta cyclo-
dextrin (mbCD) and Latrunculin A (Lat A) were used to
modify membrane organization by disrupting cholesterol-
containing rafts and caveolae (28) and actin cytoskeleton
depolymerization (29), respectively. All measurements
were conducted on live CHO-K1 plasma membranes at
37C and 5% CO2 environment unless mentioned otherwise.
Cells expressing EGFR were starved by incubation in
serum-free medium for 4 h before measurements. All
ITIR-FCS measurements were taken with a recording time
of 1 ms (for DiI-C18) or 2 ms (for GFP-GPI-AP and
ITIR-FCS Study of EGFR Organization 1927EGFR-EGFP) per frame. Note that photodynamic processes
and cytosolic diffusion of EGFR-EGFP are expected to have
characteristic times below 1 ms (30–32). They are therefore
unlikely to interfere in the quantification of the membrane
diffusion of EGFR-EGFP. We first demonstrate the applica-
bility of the FCS diffusion law to determine the organization
of live CHO-K1 cells and various model membranes. The
principle of the FCS diffusion law is provided in the Sup-
porting Material.The ITIR-FCS diffusion law describes
organization of lipids and proteins
We used three different membrane probes, namely DiI-C18,
GFP-GPI-AP, and PMT-GFP, and determined their diffusion
and confinement modes on plasma membranes (Fig. 1).
The total internal reflection fluorescence (TIRF) images of
the cells labeled with the previous probes were optically
homogeneous (Fig. 1, images). The D of DiI-C18 and GFP-
GPI-AP was 1.34 5 0.20 mm2/s and 0.31 5 0.22 mm2/s,
respectively, at 37C (see Fig. S8, blue and black). A similar
difference between DiI-C18 and GFP-GPI-AP diffusion was
reported for RBL and HeLa cells (24,33).
The FCS diffusion law analyses also showed a clear differ-
ence in the subresolution membrane heterogeneity mirrored
byDiI-C18 andGFP-GPI-AP diffusion. The t0 of DiI-C18 and
GFP-GPI-APwas0.055 0.01 s and 1.275 0.05 s, respec-
tively (Fig. 1, bottom). Note that the margin of error for the
ITIR-FCS diffusion law intercept is5 0.1 s and thus values
of t0 in that range are consistent with free diffusion (25).
After mbCD treatment, t0 of GFP-GPI-AP was reduced to
0.175 0.11 s, whereas D increased to 0.445 0.22 mm2/s.
This confirms free diffusion for DiI-C18 and cholesterol-DiI-C18 GFP-GPI-AP PMT-GFP
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FIGURE 1 Demonstration of ITIR-FCS diffusion law on live cell mem-
branes expressing different proteins or stained with lipid probes that exhibit
various modes of diffusion.dependent domain confinement for GFP-GPI-AP (34).
PMT-GFP was shown to be located in the inner leaflet of
the plasmamembrane andwas associatedwith the actin cyto-
skeleton in CHO-K1 and macrophages cells (35,36). The
values of D and t0 of PMT-GFP were 0.67 5 0.20 mm
2/s
and0.635 0.02 s, respectively (Fig. 1, bottom), suggesting
hop diffusion. When the actin cytoskeleton was disrupted, t0
increased to 0.065 0.02 s, indicating free diffusion. How-
ever, D (after treatment: 0.625 0.22 mm2/s) did not change
significantly. Thus, the diffusion of PMT-GFP is spatially
compartmentalized by the actin cytoskeleton meshwork.
These results in live cell membranes establish the potential
of the ITIR-FCS diffusion law to elucidate subresolution
localization of probe molecules (see Fig. S1 for similar mea-
surements on lipid bilayers).Spatiotemporal diffusion and organization of
EGFR on the plasma membranes in the resting
state
EGFR trapping on the plasma membranes is partially
dependent on cholesterol
The values of D of EGFR-EGFP were 0.205 0.13 mm2/s at
37C, which is slower than that of GFP-GPI-AP (0.31 5
0.22 mm2/s) (Fig. S1, red and black). In addition, the t0
values of EGFR-EGFP (1.5–2.5 s) were always larger than
that of GFP-GPI-AP (1.0–1.3 s). Therefore, overall domain
confinement of EGFR-EGFP is stronger than that of GFP-
GPI-AP. We first probe the contribution of cholesterol-
containing domains (lipid rafts and caveolae) to achieve
such strong confinement. Cells were incubated with 3 mM
mbCD and D and t0 of EGFR were monitored for up to
1 h. 3 mM mbCD is sufficient to deplete cholesterol-con-
taining domains (37,38). Since in the ITIR-FCS diffusion
law, multiple observation areas are measured in a single
FCS experiment, one can monitor the time evolution of
spatial heterogeneity of a tracer on the membrane under per-
turbing conditions (23,39).
The time-dependent change of D and t0 of EGFR-EGFP
after mbCD treatment for one representative cell is shown
in Fig. 2, A and B. The value of D increased monotonically
~40% (from0.205 0.13mm2/s to 0.285 0.17mm2/s) within
~30 min of the mbCD addition and then decreased toward
the initial value after ~50 min incubation (D ¼ 0.21 5
0.16 mm2/s) (Fig. 2, A and B, black). Fig. 2 C shows the D
distribution of EGFR-EGFP before and 30 min after mbCD
treatment. The distribution is created by pooling D values
from 5 cells. The data of individual cells is shown in
Fig. S9. The increase in overall membrane diffusion is
more obvious in the cumulative distribution of D, which
was right shifted with an unchanged slope after treatment
(Fig. 2 C, inset). Likewise, EGFR-EGFP organization
became less confined as t0 monotonically decreased by
~65% from the basal value of 1.98 5 0.72 s to the lowestBiophysical Journal 109(9) 1925–1936
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FIGURE 2 Cholesterol and actin cytoskeleton
dependence of EGFR localization on CHO-K1
cell membranes. 3 mM mbCD treatment: (A)
Change of diffusion coefficient (D, black) and
FCS diffusion law intercept (t0, gray) from one
representative cell. We could observe an overall
faster diffusion and steady disappearance of mem-
brane heterogeneity until 33 min after treatment
(dashed line, depletion). This is the time point
where mbCD is saturated with the extracted choles-
terol (solid line, saturation). This is followed by the
recovery of membrane heterogeneity (dotted line,
increase). (B) Extent of change of D and t0 over
time. (C) Distribution of D before and 33 min after
treatment (Number of ACFs ¼ 2205 and Number
of cells ¼ 5). In the inset, the cumulative distribu-
tion of the histograms is shown. (D) Representative
FCS diffusion law plots for treated and untreated
cells. The arrow represents reduction of t0. 3 mM
Lat A treatment: (E) Distribution of D before and
15 min after treatment (Number of ACFs ¼ 2205
and Number of cells ¼ 5). In the inset, cumulative
distribution of the histograms is shown. (F)
Representative FCS diffusion law plots for treated
and untreated cells. The arrow represents elevation
of t0.
1928 Bag et al.value of 0.665 0.14 s at 33 min (Fig. 2, A, B, and D, gray).
We also observed a similar time-dependent change of GFP-
GPI-AP diffusion under identical perturbing conditions
(Fig. S2, A–C, black). However, there is a significant differ-
ence in the absolute values. In the case of GFP-GPI-AP, the
value of t0 is almost zero at ~30 min posttreatment (from
1.315 0.31 s to 0.175 0.11 s) indicating free diffusion of
GFP-GPI-AP, which is released from lipid rafts after choles-
terol extraction (Fig. S2,A,B, andD, gray). In contrast, the t0
value for EGFR-EGFP decreases but remains strongly posi-
tive (0.965 0.07 s) under the same condition. This suggests
only partial cholesterol dependence of EGFR localization
and at least some cholesterol independent confinement.
On a side note, we would like to remark that t0 for
both EGFR-EGFP and GFP-GPI-AP recovered to ~70% of
the basal value after prolonged incubation with mbCD
(Fig. 2, A and B, for EGFR and Fig. S2, A and B, for GPI-
AP). In this context, we found that the decrease of t0 value
depends on the incubation time and concentration of mbCD.
The recovery of t0 after prolonged duration is due to the
saturation of mbCD (Figs. S3 A and S4 A). Therefore, if
longer observation times are required an exchange of the
mounting medium with fresh mbCD is required upon
mbCD saturation. In addition, this means that the maximumBiophysical Journal 109(9) 1925–1936effect of mbCD can be observed only in a relatively narrow
time window of ~10 min, at a time point, whose position is
dependent on the mbCD concentration.
Therefore, GFP-GPI-AP exclusively partitions into
cholesterol-containing domains where a significant amount
of EGFR-EGFP also resides. Another fraction of EGFR
shows cholesterol-independent trapping. It was earlier sug-
gested that EGFR clusters exist on the membrane in the
absence of ligand (40,41), whereas Hofman et al. showed
that EGFR resides in cholesterol-independent GM1 do-
mains in the resting state (42). Therefore, the origin of the
cholesterol-independent part of t0 could be both dynamic
formation of EGFR clusters and partitioning into choles-
terol-independent domains. Such cholesterol independent
trapping of signaling molecules in protein clusters is known
for T-cell receptors in the activated state (43). BothD and t0,
as anticipated, remained unaffected for DiI-C18-labeled
membranes, confirming that cholesterol extraction does
not affect the dynamics of the freely diffusing phospholipid
matrix (Fig. S5).
Cholesterol-dependent trapping of EGFR on the plasma
membrane is due to its localization in cholesterol-containing
domains such as lipid rafts or caveolae. Biochemical studies
showed that 40% of EGFR is localized in lipid rafts, whereas
ITIR-FCS Study of EGFR Organization 1929only 5–10% is in caveolae in HEp-2 and A431 cells (44). It
was also reported by fluorescence lifetime imaging micro-
scopy-fluorescence resonance energy transfer experiments
that EGFR in a resting state colocalizes with GM1, but not
with GPI-AP, in HER14 cells (42). The authors found that
GPI-AP colocalizes with GM1 in a cholesterol-dependent
manner implying that EGFR partitions into cholesterol-defi-
cient GM1 domains. However, the colocalization between
caveolae and EGFR was not explored. To test this, we per-
formed experiments on Jurkat T cells that lack caveolae
(45). If the cholesterol-dependent fraction of EGFR is exclu-
sively located in caveolae then cholesterol depletion from
Jurkat cells would not lead to any change in the EGFR-
EGFP confinement, although the same treatment on the
GFP-GPI-AP expressing cells would remove its choles-
terol-dependent domain confinement. The value of D of
EGFR-EGFP in Jurkat cells increased from 0.23 5 0.16
mm2/s to 0.51 5 0.39 mm2/s after mbCD treatment
(Fig. S10 A). An increase in D was also observed for GFP-
GPI-AP (before: 0.425 0.23 mm2/s and after: 0.525 0.22
mm2/s) (Fig. S10 C). For EGFR-EGFP, t0 changed from
2.61 5 0.13 s to 1.17 5 0.17 s (~56% decrease)
(Fig. S10 B). Similarly, for GFP-GPI-AP, it was 1.09 5
0.17 s (before) and 0.285 0.12 s (after) (Fig. S10 D). The
relative decrease of t0 of EGFR-EGFP after mbCD treatment
was also comparable for CHO-K1 (~65%) and Jurkat cells
(~56%). Similarly for GFP-GPI-AP, t0 decreases to values
close to 0.1 s (free diffusion). These observations indicate
that the entire cholesterol-dependent fraction of EGFR
is located in lipid rafts in the absence of caveolae (Jurkat
cells). Therefore, cholesterol-dependent confinement of
EGFR in CHO-K1 cells is unlikely to originate from locali-
zation in caveolae. This is different from EGFR organization
in HER14 cells where it is excluded from lipid rafts in the
resting state (42). Thus, localization of EGFR depends on
the cell type and availability of various types of choles-
terol-containing domains. Nevertheless, a significant frac-
tion of cholesterol-independent confinement of EGFR is
common in both CHO-K1 and Jurkat cells, whereas GFP-
GPI-AP confinement exclusively depends on cholesterol.
Similarly, the degree of confinement (t0 value) of EGFR-
EGFP is higher than that of GFP-GPI-AP, which is reflected
in their respective lateral dynamics, i.e.,D of GFP-GPI-AP is
larger than that of EGFR-EGFP in resting cells.
EGFR organization depends on actin cytoskeleton
The role of the actin cytoskeleton on EGFR organization
was studied next by treating the cells with 3 mM Lat A.
Fig. S6 shows images of CHO-K1 cells stably expressing
GFP-labeled actin (Lifeact cells) (46) before and after treat-
ment to confirm drug activity. We observed microscopic
clusters of EGFR-EGFP in ~20% of cells after the addition
of Lat A (Fig. S11 A). The average D of EGFR-EGFP,
consistent with the literature (47), increased slightly, from
0.205 0.13 mm2/s to 0.265 0.28 mm2/s, after actin depo-lymerization. A closer look at the D distribution shows that
the fraction of slow diffusing species (D < 0.1 mm2/s)
increased, whereas that of the fast diffusing species (D >
0.5 mm2/s) increased slightly after Lat A treatment
(Fig. 2 E). The species exhibiting intermediate diffusivity
(D ¼ 0.1–0.5 mm2/s) decreased moderately in population.
This is more obvious in the cumulative distribution of D
(Fig. 2 E, inset). The population of fast diffusing species in-
creases because the cytoskeleton bound EGFR is released
after treatment and they diffuse at a faster rate. On the other
hand, EGFR clustering after Lat A treatment results in a
slow diffusive fraction. The probability of receptor clus-
tering is dependent on its concentration and the meshwork
density (48,49). At low receptor concentration, which is
the case here, the cytoskeleton compartments inhibit recep-
tor clustering. However, the receptors are spatially less
constrained in the absence of a meshwork and thus the prob-
ability of cluster formation increases.
The t0 value increased ~55% after cytoskeleton disrup-
tion (t0 ¼ 1.57 5 0.11 s to 2.46 5 0.10 s) (Fig. 2 E).
This is reminiscent of what was observed for PMT-GFP
(Fig. 1 B). The reduction and elevation of the t0 value after
mbCD and Lat A treatment, respectively, confirm the influ-
ence of both, membrane domains and cytoskeleton mesh-
work, on EGFR organization. A similar phenomenon was
also observed for other transmembrane proteins such as di-
peptidyl peptidase IV (DPPIV-GFP) on live COS-7 cells (38)
and NKp46 receptor on hyporesponsive natural killer (NK)
cells (50). A negligible effect on D and t0 was observed
upon the same treatment on either GFP-GPI-AP transfected
or DiI-C18 stained cells (Fig. S7). Therefore, the membrane
organization of GFP-GPI-AP and lipids, in concordance
with the previous reports (36,38,51), is not strongly affected
by the actin cytoskeleton in live cells.
Our results suggest that EGFR lateral dynamics and orga-
nization is dictated by its confinement in membrane do-
mains and compartmentalization by the actin cytoskeleton
in the resting state. The cholesterol-dependent domains
are mainly lipid rafts with little contribution of caveolae.
A cholesterol-independent transient trapping of EGFR is
also identified. The source of this trapping could be either
cholesterol-deficient lipid domains or EGFR nanoclusters.
It was earlier pointed out that EGFR binds to gangliosides,
which could potentially be one of the sources of cholesterol-
independent trapping of the receptor (52). The domain
confinement is the major mediator of EGFR spatial organi-
zation on membranes because we observed an overall posi-
tive t0 value in unperturbed cell membranes.Spatiotemporal diffusion and organization of
EGFR on the plasma membrane in the
ligand-bound state
In this section, we focus on the organization of EGFR after
stimulation with its extracellular ligand, EGF. It is believedBiophysical Journal 109(9) 1925–1936
1930 Bag et al.that EGF binding to EGFR leads to receptor dimerization,
which is the first step of receptor activation (48). In addition,
large microscopic clusters, which amplify EGFR signaling,
are also shown to form after EGF binding (53). Ligand-
bound EGFR internalizes via different endocytosis routes
depending on the ligand dose (54). The major internaliza-
tion pathways are clathrin-mediated (CE) and nonclathrin-
mediated endocytosis (NCE) at a low and high dose of
EGF, respectively, where NCE is reported to attenuate
EGFR signaling (54,55). This suggests that ligand binding,
activation, and internalization of EGFR are closely coupled
with its localization on the membrane (56,57). However,
experimental evidence both supports (58,59) and disputes
(57,60) that localization of EGFR in membrane domains
promotes EGFR signaling. This ambiguity could well
stem from the experimental difficulties that arise from the
nanoscopic size of the membrane domains or deleterious ef-
fects of chemical treatments. Here, we performed time-lapse
confocal imaging to monitor ligand-induced EGFR clus-
tering and endocytosis (61,62). In parallel, we employed
TIRF imaging and ITIR-FCS in tandem to elucidate the
state of EGFR diffusion and organization above and below
the resolution limit upon low and high doses of EGF stimu-
lation. We estimated the cell surface density of EGFR-EGFP
to be 20,000–200,000 molecules per cell by confocal
FCS, which coincides with reported physiological levels
(27,63). This covers the range where 10 and 100 ng/mL of
EGF represents low and high dose ligand concentrations
(Table S1) (54). We finally studied the contribution of
cholesterol-dependent domains and the actin cytoskeleton
in EGF-induced modulation of EGFR dynamics.
EGFR clustering and endocytosis after EGF stimulation
depends on ligand dose
Time lapse confocal imaging showed the formation of a
negligible amount of EGFR clusters on the membrane after
10 ng/mL EGF stimulation (Fig. S12 A). Moreover, we
observed intracellular fluorescence, although the membrane
fluorescence did not change significantly. This is probably
due to dynamic recycling of the ligand-bound EGFR, as pro-
posed earlier for low dose stimulation (54). The retention of
membrane fluorescence was also observed in the TIRF im-
ages (Fig. 3 A). On the contrary, macroscopic EGFR-EGFP200
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Biophysical Journal 109(9) 1925–1936clusters were formed on the plasma membrane after addition
of 100 ng/mL EGF (Fig. S12 B). These clusters internalized
(13–20 min, Fig. S12 B) and gradually disappeared over
time (20 min onward, Fig. S12 B). A significant drop of
membrane signal was also observed in the TIRF images
(Fig. 3 B). The permanent reduction of membrane fluores-
cence and gradual fading of intracellular fluorescence could
be due to the degradation of the internalized EGFR (54). As
a control, GFP-GPI-AP expressing and DiI-C18 stained cells
were incubated with 100 ng/mL of EGF. We did not observe
any cluster of GFP-GPI-AP on the membrane as expected
(Fig. S13 A). Endocytosis of GFP-GPI-AP after EGF treat-
ment was also not observed (Fig. S12 C). Overall, EGF
binds to EGFR to form clusters on the membrane, which
are eventually internalized. The cluster formation is EGF
concentration dependent.
Modulation of EGFR membrane diffusion in relation to EGF
concentration
We measured the change of membrane diffusion and hetero-
geneity of the remaining EGFR after EGF stimulation. At a
low dose of EGF (10 ng/mL) both D (before: 0.20 5
0.13 mm2/s and after: 0.21 5 0.13 mm2/s) and t0 (before:
1.695 0.12 s and after: 1.645 0.10 s) of EGFR-EGFP re-
mained unchanged (Fig. 4, A and B, respectively). Thus, low
dose stimulation of EGF does not change membrane dy-
namics and confinement of EGFR while receptor internali-
zation still occurs but probably with receptor recycling.
After 100 ng/mL EGF stimulation, a small but significant
time-dependent change of D of EGFR-EGFP was recorded
(Fig. 4, C and D). The average D increased with time by
35% (from 0.20 5 0.13 mm2/s to 0.27 5 0.17 mm2/s;
Kolmogorov-Smirnov (KS) test p < 0.001), whereas t0 re-
mained unaltered and positive after ~15–20 min stimulation
(before: 1.85 5 0.12 s and after: 1.93 5 0.08 s) (Fig. 4,
C–F). The trend of the temporal change of D was similar
to that of mbCD treatment while, for t0, it significantly
differed (Figs. 2 B and 4 D for mbCD and EGF treatment,
respectively). Therefore, as expected, it is not a common
mechanism that modifies EGFR-EGFP diffusion on the
membrane upon EGF and mbCD treatments, although the
average D after these treatments was very similar (0.28 5
0.17 mm2/s for mbCD and 0.27 5 0.17 mm2/s for EGF).35002500
- EGF + EGF
FIGURE 3 Fluorescence intensity histograms
and TIRF images of EGFR-EGFP expressing
CHO-K1 cells before and 20 min after stimulation
with (A) 10 ng/mL and (B) 100 ng/mL EGF. The
fluorescence intensity (before: gray; after: black)
stayed constant at 10 ng/mL but was reduced at
100 ng/ml. The peaks at the extreme left side of
both figures are due to electronic background.
The scale bar is 5 mm.
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FIGURE 4 Effect of EGF stimulation on the dy-
namics and organization of EGFR. (A) D distribu-
tion (Number of ACFs ¼ 2205 and Number of
cells ¼ 5) and (B) FCS diffusion law plot before
and 20 min after 10 ng/mL EGF stimulation for
one representative cell. (C) Change of diffusion co-
efficient (D, black) and FCS diffusion law intercept
(t0, gray) over time after stimulation with 100 ng/
mL EGF for one representative cell. (D) Extent
of change of D and t0 over time for the same treat-
ment. (E) Distribution of D before and 20 min
after stimulation with 100 ng/mL EGF (Number
of ACFs ¼ 2205 and Number of cells ¼ 5). In
the inset the cumulative distribution of the histo-
grams is shown. (F) Representative FCS diffusion
law plots for treated and untreated cells.
ITIR-FCS Study of EGFR Organization 1931An interesting feature can be spotted when the D distribu-
tion (both histogram and cumulative) of the EGFR after
mbCD and EGF treatments is compared. There was a strik-
ing drop on the fraction of slow diffusing particles (D < 0.1
mm2/s) after EGF stimulation in a similar fashion to that af-
ter mbCD treatment (Figs. 4 C and S14 A). However, the
fast diffusing fraction in case of EGF stimulation did not in-
crease to the same extent compared to the mbCD treatment.
In both cases, the cumulative distribution right shifted from
that of the resting state. But the slope of the cumulative plot
did not change for mbCD treatment as opposed to the case
of EGF stimulation where the slope became steeper
(Fig. S14 B, green versus black). Therefore, mbCD causes
a global change in EGFR diffusion, whereas the slow
diffusing fraction on the membrane surface disappears
selectively on EGF stimulation.
The D distribution of GFP-GPI-AP did not change after
100 ng/mL EGF addition (before: 0.31 5 0.22 mm2/s and
after: 0.32 5 0.22 mm2/s). Similarly, the t0 value before
(1.15 5 0.07 s) and after (1.24 5 0.07 s) treatment also
shows no prominent change in subresolution domain
organization (Fig. S13, B and C). Similar effects were
also observed for DiI-C18 diffusion and organization
(Fig. S13, D and E). This confirms that EGF has no influ-ence on GFP-GPI-AP containing cholesterol-dependent
domains and the phospholipid-enriched bilayer matrix on
resting plasma membranes.
The relationship of EGFR membrane diffusion, confinement,
and the mode of internalization in the ligand-bound state
The D distribution of EGFR-EGFP following EGF stimula-
tion can be linked to the mode of endocytosis. The major
route of receptor internalization is CE. In this mechanism,
the receptor is transported via clathrin-coated pits into early
endosomes followed by late endosome localization where
the fate of the receptor, whether to degrade at the lysosome
or to recycle to the membrane, is decided. In contrast,
cholesterol-containing domains are involved in NCE. As a
result, cholesterol-containing domains disappear from the
membrane. Because EGFR is partially localized in choles-
terol-dependent domains, NCE of the receptor changes its
membrane diffusion. But if cholesterol-dependent domains
do not participate in the internalization, as in the case of
CE, EGFR diffusion remains unaffected. We also tested
NCE by monitoring endocytosis of GFP-GPI-AP and
EGFR-mRFP cotransfected cells at a given EGF dose.
The fluorescence signal on the membrane hardly changed
after 10 ng/mL EGF stimulation (Fig. 3 A). In addition, aBiophysical Journal 109(9) 1925–1936
1932 Bag et al.few EGFR clusters on the membrane along with intracel-
lular fluorescence were observed (Fig. S12 A). Both
membrane and intercellular signal did not vanish after pro-
longed incubation, nor did the average membrane diffusivity
of EGFR change. In the cytosol, we observed fluorescence
of EGFR-mRFP but not of GFP-GPI-AP after treatment of
10 ng/mL EGF on the cotransfected cells (Fig. S15 A).
This implies that GFP-GPI-AP containing cholesterol-
dependent domains are not involved in the endocytosis.
We therefore rule out the possibility of NCE to be an inter-
nalization pathway here. Sigismund et al. reported that the
EGFR undergoes CE and is recycled to the membrane after
a low dose of ligand stimulation (54). Persistent intracellular
fluorescence signal since its first appearance and unchanged
membrane fluorescence in our experiments suggests recep-
tor recycling to the membrane after internalization. The D
and t0 values for EGFR after 10 ng/mL EGF stimulation
were unchanged because the trapping sites are not involved
in the endocytosis.
After 100 ng/mL EGF addition, we observed both green
and red fluorescence in endocytosed clusters of GFP-GPI-
AP and EGFR-mRFP cotransfected cells (Fig. S15 B).
The regions in the cell interior that were devoid of clusters
had high amounts of EGFR-mRFP, which did not coloc-
alize with GFP-GPI-AP. The endocytosis of GFP-GPI-
AP confirms that the cholesterol-dependent domains are
endocytosed and thus it is an NCE process. Note that
GFP-GPI-AP itself does not endocytose after EGF treatment
in the absence of EGFR (Fig. S12 C). In addition, the intra-
cellular EGFR-mRFP signal, which does not colocalize
with GFP-GPI-AP suggest a CE process. Interestingly, the
average membrane diffusion of the EGFR-EGFP increased
(Fig. 4 E). This D distribution shows that a slow diffusing
(D < 0.1 mm2/s) fraction of EGFR disappeared, whereas
the fast diffusing fraction remained unaffected (Fig. 4 E
and inset). The disappearance of the slow diffusing fraction
is due to the removal of more ordered and viscous (less
fluid) cholesterol-containing domains during NCE. In addi-
tion, the fluorescence signal from the membrane did not
recover after prolonged incubation, although the internal-
ized clusters that were observed after EGF stimulation
(Figs. 3 B and S12 B) gradually disappeared over time, sug-
gesting degradation of internalized EGFR. This matches
well with the literature, which states that ~40% of EGFR
is endocytosed via NCE after stimulation with a high dose
of EGF and the majority degrades over time (54,64). A
recent study shows that the completion of the internalization
process takes ~15 min after ligand stimulation (65). This is
about the time when we observed the maximum diffusivity
of the EGFR on the membranes after EGF stimulation infer-
ring the disappearance of the cholesterol-containing
domains to the highest extent (Fig. 4 D). Therefore, one
of the internalization pathways of EGFR after stimula-
tion with 100 ng/mL EGF is nonclathrin-mediated and
cholesterol-dependent endocytosis. Abulrob et al. also re-Biophysical Journal 109(9) 1925–1936ported similar endocytosis and degradation of the domains
of intermediate size followed by EGFR recycling to the
membrane (66).
An interesting feature in the organization of EGFR-EGFP
should be noted here. The t0 value did not change after
100 ng/mL EGF stimulation. Therefore, the fraction of
membrane area that could trap EGFR remained the same,
although cholesterol-containing domains were partially
removed during endocytosis. Sergeev et al. reported that
the binding of EGF increases the number and size of
EGFR clusters (67). EGF also introduces large domains
by coalescing various membrane domains (42,68). The ex-
istence of these larger nanoclusters/domains would there-
fore compensate the loss of confinement due to the
removal of cholesterol-containing domains and thus result
in almost constant t0 values. The possibility of formation
of macroscopic clusters was tested at a higher concentration
of EGF (500 ng/mL). We indeed observed large clusters on
the membrane (Fig. S16 A) along with endocytosed clusters
inside the cells (Fig. S16 B).
Overall, the interaction of EGF with membrane-bound
EGFR is strongly dependent on EGF concentration. At
low dose (10 ng/mL), EGFR internalizes probably via CE
with an unchanged membrane diffusion and confinement.
At high dose (100 ng/mL), EGFR undergoes both CE and
NCE, which leads to a time-dependent increase of its mem-
brane diffusion. In parallel, the remaining EGFR on the
membrane assembles into nanoclusters with a larger size
and density. The last point was supported by the observation
of receptor clustering at even higher dose stimulation
(500 ng/mL).
Involvement of cholesterol-dependent domains in
EGF-induced EGFR endocytosis
We next investigated the effects of EGF on EGFR organiza-
tion when the latter is released from cholesterol-dependent
domains. The cells were first incubated with 3 mM mbCD
for 30 min. At this time point, i.e., when the maximum effect
of mbCD in terms of D and t0 was observed Fig. 2 A),
10 ng/mL of EGF was added to the system. We did not
observe any microsocpic clusters on the membrane. Inter-
estingly, the t0 value at this condition increased significantly
(untreated: 2.145 0.17 s, mbCD: 1.185 0.15 s, mbCD þ
EGF: 3.00 5 0.17 s) (Figs. 5 A and S17 A). This could be
due to the existence of nanosclusters (67,69). In contrast,
microscopic EGFR clusters were observed on the membrane
even after 20 min of 100 ng/mL EGF stimulation on choles-
terol-depleted cells (Fig. S17 C). These clusters are, in gen-
eral, randomly distributed over the cell surface, although in
some cases they are more populated in the cell periphery
(70). This is consistent with the work of Saffarian et al.,
who reported EGFR clustering on the membrane after
cholesterol depletion (71). FCS diffusion law analysis on
the membrane regions that were devoid of clusters gave a
much larger positive intercept (t0 ¼ 3.70 5 0.19 s) than
ITIR-FCS Study of EGFR Organization 1933that of the resting membrane (t0¼ 1.895 0.09 s) (Figs. 5 B
and S17 B), indicating a larger surface coverage of the nano-
scopic clusters compared to the basal state. As a control,
serum-starved EGFR-EGFP expressing CHO-K1 cells
were incubated with mbCD for 30 min followed by washing
out of mbCD with serum-free medium that does not contain
EGF. We observed a recovery of t0 that does not exceed the
basal value for the untreated plasma membrane (Fig. S4 B).
We, however, did not notice any substantial change in the D
of EGFR after EGF stimulation (Fig. 5, A and B).
The internalization of EGFR under cholesterol depletion,
as observed by confocal imaging, is impaired for both 10
and 100 ng/mL EGF stimulation (Fig. S18). Pike and Casey
also reported a similar observation (60). Overall, EGFR
membrane organization and internalization behavior post
EGF stimulation strikingly differ in resting (Fig. S12) and
cholesterol-depleted CHO-K1 cells (Fig. S18). Cholesterol
depletion followed by EGF stimulation thus has two effects:
impairment of the internalization of EGFR and stronger
confinement of the EGFR on the membranes probably by
formation of larger and numerous EGFR clusters.
The actin cytoskeleton promotes internalization of EGFR
clusters after EGF stimulation
The role of the actin cytoskeleton in endocytosis was inves-
tigated because EGFR is an actin binding protein and its or-
ganization is compartmentalized by the actin cytoskeleton
(72). To test this, we performed TIRF imaging on EGFR-
EGFP expressing cells after 3 mM Lat A treatment for
15 min, followed by EGF stimulation for 20 min. Lat A
treatment, as stated earlier, induces clustering of the
EGFR-EGFP on the plasma membranes of ~20% of the cells
(Fig. S11 A). In contrast, ~80% of cells exhibit plasma mem-
brane clustering of EGFR-EGFP when EGF (both 10 and
100 ng/mL) is added to the cytoskeleton depleted cells
(Fig. S11, B and C). We then probed any possible changes
in the actin organization during the internalization process.
Confocal images of Lifeact cells were taken after EGF stim-
ulation of normal and mbCD-treated cells (Fig. S19). In
both cases, we did not observe any microscopic change in
cytoskeletal organization. Therefore, involvement of the1.0
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and its impairment after cholesterol depletion is not
associated with macroscopic actin reorganization. The coor-
dination of cholesterol-containing domains and the cyto-
skeleton is necessary for EGFR endocytosis after a high
dose of EGF stimulation because removal of one of them
undermines endocytosis and allows EGFR clusters to
remain on the membrane for a prolonged duration. We
also tested the role that the actin cytoskeleton plays in the
interaction between EGF and GPI-AP. GFP-GPI-AP ex-
pressing cells were treated first with 3 mM Lat A for
15 min followed by 100 ng/mL of EGF for 20 min and
imaged in TIRF at each step of the treatments. We did not
observe any GFP-GPI-AP cluster on the plasma membrane
(Fig. S20). This is expected since GFP-GPI-AP was earlier
shown to be unaffected by the perturbation of actin organi-
zation (Fig. S7). Overall, EGFR clustering (Figs. S17 C and
S11) on the membrane is mediated by both cholesterol and
the cytoskeleton.CONCLUSIONS
The current ITIR-FCS study investigates the spatial distri-
bution of diffusion of EGFR-EGFP on CHO-K1 plasma
membranes via the FCS diffusion law in ITIR-FCS. For
this purpose we contrast EGFR dynamics and organization
with that of DiI-C18 and GFP-GPI-AP. We show, by choles-
terol depletion experiments, that GFP-GPI-AP is partitioned
into cholesterol-containing domains, whereas DiI-C18 is
insensitive to cholesterol and exhibits free membrane diffu-
sion. It should be noted here that cholesterol depletion by
mbCD from the membrane is strongly dependent on con-
centration and time of measurement. For instance, 3 and
5 mM mbCD show their maximum effect at very different
times (~30 and 15 min after addition, respectively) at which
they become saturated. The membrane then gradually re-
stores its heterogeneity presumably from replenishing of
cholesterol from internal stores. Therefore, measurements
after mbCD treatment have to be performed at a specific
time and a narrow time window (~5–10 minutes) to obtain
a maximal effect.3
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FIGURE 5 Effect of different doses of EGF on
the diffusion and heterogeneity of cholesterol
depleted EGFR-EGFP expressing CHO-K1 cells.
(A) 3 mM mbCD for 30 min followed by
10 ng/mL EGF for 20 min, and (B) 3 mM mbCD
for 30 min followed by 100 ng/mL EGF for
20 min. The t0 values after (mbCD þ EGF) for
both cases are larger than the spontaneous recov-
ered values in case of only mbCD treatment for
50 min (Figs. 1 A and S2 B). Measurements were
done on 3 cells and 1323 ACFs were analyzed at
each state of drug treatment.
Biophysical Journal 109(9) 1925–1936
1934 Bag et al.Our experiments provide evidence of nanoscopic confined
diffusion of EGFR in resting cell membranes by cytoskel-
eton-based compartmentalization and transient trapping in
membrane domains. The domain trapping is only partially
dependent on cholesterol. Partitioning into cholesterol-inde-
pendent domains and/or receptor nanoclustering lead to
cholesterol-independent trapping of EGFR. Cholesterol-
dependent localization of EGFR-EGFP does not require
the presence of caveolae. Similar cholesterol dependent
and independent trapping is also known for other recep-
tors including T cell and G-protein-coupled receptors
(43,73–75). The actin cytoskeleton also plays a significant
role in restricting receptors from forming microscopic clus-
ters. EGF, an extracellular ligand of EGFR, modifies the
membrane diffusion, clustering, and endocytosis of EGFR-
EGFP. Ligand-bound EGFR-EGFP forms clusters that
endocytose afterward. The number and size of clusters de-
pends on the ligand dose. Cholesterol-containing domains
are involved in the endocytosis only at high dose stimulation,
which leads to faster membrane diffusion of the remaining
EGFR. The dynamics and organization of GFP-GPI-AP, as
expected, does not change upon EGF treatment.
Cholesterol and the actin cytoskeleton play significant
roles in the membrane clustering of ligand-bound EGFR.
Cholesterol depletion impairs endocytosis of ligand-bound
EGFR clusters. This allows the clusters to stay on the
membrane for a prolonged duration. This could increase
EGFR signaling competency (60,71). Cholesterol-indepen-
dent EGFR trapping observed here may also play a role in
the activation of EGFR after cholesterol depletion. The
ligand-bound EGFR clusters on the membrane, regardless
of ligand dose, were also observed on actin cytoskeleton-
depleted cells. Overall, this study addresses how different
membrane organizational principles contribute to EGFR
localization and ligand binding on the plasma membranes
and also illustrates the link between EGFR endocytosis
and modulation of membrane diffusion, confinement, and
clustering after EGF binding.SUPPORTING MATERIAL
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